These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22108836)

  • 21. Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster.
    Kyoi S; Otani H; Matsuhisa S; Akita Y; Tatsumi K; Enoki C; Fujiwara H; Imamura H; Kamihata H; Iwasaka T
    Cardiovasc Res; 2006 Mar; 69(4):888-98. PubMed ID: 16375879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombosis and embolism in pediatric cardiomyopathy.
    Chen K; Williams S; Chan AK; Mondal TK
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):221-30. PubMed ID: 23429248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological left ventricular reverse remodeling in elderly patients receiving optimal therapy for chronic heart failure.
    Cioffi G; Tarantini L; De Feo S; Pulignano G; Del Sindaco D; Stefenelli C; Opasich C
    Eur J Heart Fail; 2005 Oct; 7(6):1040-8. PubMed ID: 16227142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboembolic complications in patients with newly diagnosed dilated cardiomyopathy immediately after initiation of congestive heart failure treatment: just a coincidence or should we pay more attention?
    Yetkin E; Topal E; Yanik A; Ozten M
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):480-2. PubMed ID: 19520683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-blockers and reverse remodeling: what are the implications?
    Francis GS; Tang WH
    Am Heart J; 2003 Feb; 145(2):200-2. PubMed ID: 12595832
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
    Maunoury C; Acar P; Sidi D
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1651-6. PubMed ID: 14504829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy.
    Alexander PM; Daubeney PE; Nugent AW; Lee KJ; Turner C; Colan SD; Robertson T; Davis AM; Ramsay J; Justo R; Sholler GF; King I; Weintraub RG;
    Circulation; 2013 Oct; 128(18):2039-46. PubMed ID: 24036608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of beta-blockers in left ventricular dysfunction and heart failure.
    Hjalmarson A; Kneider M; Waagstein F
    Drugs; 1997 Oct; 54(4):501-10. PubMed ID: 9339958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of amiodarone treatment on cardiac symptom, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with beta-blocker therapy.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
    J Nucl Cardiol; 2004; 11(2):134-41. PubMed ID: 15052244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome predictors in dilated cardiomyopathy or myocarditis.
    Kuethe F; Franz M; Jung C; Porrmann C; Reinbothe F; Schlattmann P; Egerer R; Mall G
    Eur J Clin Invest; 2017 Jul; 47(7):513-523. PubMed ID: 28556177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
    Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
    Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe left ventricular dysfunction in infants with ventricular preexcitation.
    Cadrin-Tourigny J; Fournier A; Andelfinger G; Khairy P
    Heart Rhythm; 2008 Sep; 5(9):1320-2. PubMed ID: 18774110
    [No Abstract]   [Full Text] [Related]  

  • 37. Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters.
    Hayashi K; Kimata H; Obata K; Matsushita A; Fukata A; Hashimoto K; Noda A; Iwase M; Koike Y; Yokota M; Nagata K
    J Card Fail; 2008 Apr; 14(3):238-44. PubMed ID: 18381188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters.
    Crespo MJ; Cangiano JL; Altieri PI; Escobales N
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):547-52. PubMed ID: 22370958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of echocardiographic features of noncompaction of the left ventricle in adults versus idiopathic dilated cardiomyopathy in adults.
    Sengupta PP; Mohan JC; Mehta V; Jain V; Arora R; Pandian NG; Khandheria BK
    Am J Cardiol; 2004 Aug; 94(3):389-91. PubMed ID: 15276116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.